SES AI Sets Dec 10 Vote on 5:1-20:1 Reverse Split to Cure NYSE Deficiency
SES sits 63% above its 52-week low of $0.491.
Summary
SES AI's definitive proxy schedules the December 10, 2026 annual meeting, where shareholders vote on a 5:1 to 20:1 reverse split intended to cure the NYSE sub-$1.00 deficiency before the January 17, 2027 deadline, plus a new officer exculpation amendment.
Key Events · Corporate Governance and Compliance · SES
-
Reverse Split Vote Set for December 10
Shareholders will vote December 10, 2026 on authorizing the Board to effect a reverse split of Class A common stock at a ratio between 5:1 and 20:1, with the exact ratio set by the Board and the right to abandon the split retained.
-
NYSE Cure Deadline January 17, 2027
The company is not in compliance with NYSE Section 802.01C, which requires a $1.00 average closing price over 30 trading days; if the deficiency is not cured by January 17, 2027, the NYSE will begin delisting proceedings, subject to appeal.
-
New Officer Exculpation Proposal Added
Proposal 5 would amend the charter to eliminate monetary liability of certain officers for duty-of-care breaches to the extent permitted by DGCL Section 102(b)(7); it requires two-thirds of outstanding voting power.
-
CEO Controls 58.7% of Voting Power
Dr. Qichao Hu beneficially owns all 43,881,251 Class B shares (10 votes each) and about 2.0 million Class A shares, giving him 58.7% of total voting power; the company relies on the NYSE controlled-company exemption.
Analysis · SES · Manufacturing
The definitive proxy puts a hard date on the reverse split authorization: shareholders vote December 10, 2026 on giving the Board power to combine Class A shares at any ratio from 5:1 to 20:1. That authority is the company's main tool to lift the share price back above $1.00 and avoid NYSE delisting by the January 17, 2027 cure deadline. A new officer exculpation proposal also appears in the proxy, which confirms Dr. Hu controls 58.7% of voting power — so the outcome rests largely with insiders and index holders rather than a broad retail vote. Approval alone does not change the share count: the Board must still choose a ratio and file the amendment, and it can abandon the split if the price recovers on its own.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SES was trading at $0.80 on NYSE in the Manufacturing sector, with a market capitalization of approximately $282M. The 52-week trading range was $0.49 to $2.64. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.